MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
3728.31%
Quick Ratio
3728.31%
Cash Ratio
621.59%
Debt to Asset Ratio
2.73%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Prepaid expenses
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Total current liabilities
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
54,302
19,412
18,914
56,869
Marketable securities
264,568
152,371
169,346
138,058
Prepaid expenses
4,263
2,216
1,263
1,375
Other current assets
2,572
2,122
2,133
1,997
Total current assets
325,705
176,121
191,656
198,299
Operating lease right-of-use assets
542
610
677
741
Property, equipment and leasehold improvements
-
-
537
-
Less accumulated depreciation and amortization
-
-
359
-
Property, equipment and leasehold improvements, net
336
265
178
213
Other non-current assets
3,935
2,610
928
103
Finance lease right-of-use assets
-
-
0
0
Total assets
330,518
179,606
193,439
199,356
Accounts payable
3,098
2,215
3,911
2,709
Accrued expenses
5,309
4,582
5,531
6,036
Operating lease liabilities
329
318
307
296
Finance lease liabilities
-
-
0
0
Total current liabilities
8,736
7,115
9,749
9,041
Operating lease liabilities
276
364
446
527
Total liabilities
9,012
7,479
10,195
9,568
Common stock 0.001 par value 400,000,000 and 200,000,000 shares authorized at june 30, 2026 and december 31, 2025, respectively and 142,420,883 and 128,306,056 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
142
128
128
128
Additional paid-in capital
682,582
515,185
512,772
511,118
Accumulated other comprehensive (loss) income
-425
-190
148
30
Accumulated deficit
-360,793
-342,996
-329,804
-321,488
Total stockholders equity
321,506
172,127
183,244
189,788
Total liabilities and stockholders equity
330,518
179,606
193,439
199,356
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$264,568K (204.71%↑ Y/Y)Cash and cashequivalents$54,302K (-53.61%↓ Y/Y)Prepaid expenses$4,263K (141.39%↑ Y/Y)Other current assets$2,572K (63.09%↑ Y/Y)Total current assets$325,705K (57.17%↑ Y/Y)Other non-currentassets$3,935K (5686.76%↑ Y/Y)Operating leaseright-of-use assets$542K (-32.59%↓ Y/Y)Property, equipment andleasehold improvements,...$336K (40.59%↑ Y/Y)Total assets$330,518K (58.64%↑ Y/Y)Total liabilities andstockholders equity$330,518K (58.64%↑ Y/Y)Total stockholdersequity$321,506K (61.97%↑ Y/Y)Total liabilities$9,012K (-8.47%↓ Y/Y)Accumulated deficit-$360,793K (-16.50%↓ Y/Y)Accumulated othercomprehensive (loss) income-$425K (-1870.83%↓ Y/Y)Additional paid-in capital$682,582K (34.36%↑ Y/Y)Total currentliabilities$8,736K (-5.46%↓ Y/Y)Operating leaseliabilities$276K (-54.38%↓ Y/Y)Common stock 0.001 parvalue 400,000,000 and...$142K (16.39%↑ Y/Y)Accrued expenses$5,309K (-11.24%↓ Y/Y)Accounts payable$3,098K (4.17%↑ Y/Y)Operating leaseliabilities$329K (15.03%↑ Y/Y)

Trevi Therapeutics, Inc. (TRVI)

Trevi Therapeutics, Inc. (TRVI)